Company intelligence / Profile preview
Greenlife
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
Overview
Greenlife Pharmaceuticals Limited is a leading indigenous pharmaceutical company in Nigeria, established in 1995 with a mission to provide high-quality and affordable healthcare solutions. The company is a market leader in the anti-malarial segment, most notably through its flagship brand Lonart, which is widely used across West Africa. Greenlife maintains an extensive portfolio of over 120 products, including anti-infectives, analgesics, cardiovascular medications, and nutritional supplements. With a robust distribution network and a commitment to international quality standards, the company plays a critical role in improving access to essential medicines in the region.
- Therapeutic areas
- CardiovascularImmunologyNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Greenlife.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Greenlife.